Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (187), Pregnancy
...of pre-eclampsia. This parallel-group, double-blind, placebo-controlled, randomized study was dubbed DEEP (Digoxin Immune Fab (DIF) Efficacy Evaluation in Pre-eclampsia). It enrolled fifty-one women with severe ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (650), Pregnancy Complications
...of pre-eclampsia. This parallel-group, double-blind, placebo-controlled, randomized study was dubbed DEEP (Digoxin Immune Fab (DIF) Efficacy Evaluation in Pre-eclampsia). It enrolled fifty-one women with severe ...
View Page

3.  Study Posting (77) Trial #141972, Pulmonary Arterial Hypertension, New Hyde Park, NY
...30 days (including but not limited to oxygen, a different category of vasodilator, diuretic, or digoxin) • Have had any PAH medication discontinued in the past 30 days • Have any other relative ...
View Page

4.  Study Posting (1570) Trial #156489, Heart Failure, Morristown, NJ
...pregnancy test in females of childbearing potential; • Systolic blood pressure 120 mmHg; • Oral treatment with digoxin within one week before current hospitalization; • Any inotrope administered during the current hospitalization • Presence of ...
View Page

5.  Newly Approved Drug Therapies (597) Tequin, Bristol-Myers Squibb,
...adolescents (less than 18 yr), pregnant or lactating women. There is a slight interaction with Digoxin; other drugs are largely not affected. Like other quinolones, Tequin should be used with caution ...
View Page

6.  Newly Approved Drug Therapies (598) Diltiazem HCL, Extended-Release Capsules, Biovail Laboratories,
...be some drug interactions between Diltiazem HCL and aspirin, beta-blockers, digitalis preparations, carbamazepine, cyclosporine, digoxin, lithium, oral diabetes agents, phenytoin, rifampin, cimetidine, fluvoxamine, or ranitidine. Warning Suddenly discontinuing use of ...
View Page

7.  Newly Approved Drug Therapies (944) Tykerb (lapatinib), GlaxoSmithKline,
...ability of steady-state lapatinib dosing to alter the pharmacokinetics of a single dose of digoxin. A positive finding in this study may initiate a need for further studies. Protocol Submission ...
View Page

8.  Newly Approved Drug Therapies (890) Vaprisol (conivaptan), Astellas,
...that the drug significantly increased maximum concentrations and serum halflife of the P-glycoprotein substrate digoxin, and levels of that drug should be closely monitored during Vaprisol therapy. Finally, animal models ...
View Page

9. Clinical Trial Results by Drug Names
...77% in those receiving spironolactone, 75% in those receiving diuretics and 76% in those receiving digoxin. Tolerability according to age was as follows:.70-75 years, 84%; 76-80 years, 77% ...
View Page